CG
GRTS

Column Group’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Column Group’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-869,493
Closed -$3.43M – 7
2020
Q4 		$3.43M Buy
+869,493
New +$2.63M 0.31% 7

Other funds holding GRTS

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Column Group's GRTS Position: Q1 2021 in Review

Column Group sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q1 2021, closing a stake of 869,493 shares — an estimated $3.43M sold.

Column Group first reported a position in GRTS in Q4 2020 and held it in 1 quarter. The position peaked at $3.43M in Q4 2020. 99 funds tracked by Wall St. Rank hold GRTS as of Q1 2021.

  • Column Group reported no remaining Gritstone bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Column Group sold 869,493 Gritstone bio, Inc. Common Stock shares in Q1 2021, an estimated $3.43M.
  • Column Group first reported a position in Gritstone bio, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Column Group's Gritstone bio, Inc. Common Stock position peaked at $3.43M in Q4 2020.
  • 99 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q1 2021.

Based on Column Group's 13F filing for Q1 2021, filed 17 May 2021.